GTS Securities’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,590
| Closed | -$68.7K | – | 1666 |
|
|
2024
Q4 | $68.7K | Buy |
+22,590
| New | +$68.7K | ﹤0.01% | 1180 |
|
|
2024
Q3 | – | Sell |
-10,908
| Closed | -$28K | – | 2276 |
|
|
2024
Q2 | $28K | Sell |
10,908
-28,736
| -72% | -$73.9K | ﹤0.01% | 1482 |
|
|
2024
Q1 | $195K | Sell |
39,644
-3,103
| -7% | -$15.3K | ﹤0.01% | 1211 |
|
|
2023
Q4 | $376K | Buy |
+42,747
| New | +$376K | ﹤0.01% | 1037 |
|
|
2023
Q3 | – | Sell |
-11,024
| Closed | -$279K | – | 2011 |
|
|
2023
Q2 | $279K | Buy |
+11,024
| New | +$279K | 0.01% | 925 |
|